October 10, 2015
BVBiomed Ltd. presented the latest work on relaxin in the animal model of multiple sclerosis EAE. The positive results in this study support relaxin as a potential new treatment of multiple sclerosis.
BVBiomed featured in 2018 over of MS market.
January 30, 2018
Relaxin May Promote Remyelination
April 7, 2016
BVBiomed Ltd. Presents at ECTRIMS 2015
I'm busy working on my blog posts. Watch this space!
January 2018 (1)
April 2016 (1)
October 2015 (1)